AMIA Advises FDA on Clinical Decision Support

In response to the U.S. Food and Drug Administration’s (FDA) invitation to participate in a public workshop related to FDA’s Draft Guidance on mobile medical applications, AMIA—the association for informatics professionals—advised the FDA on how it should approach oversight of clinical decision support systems.

Click here to read the official AMIA news release.